Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image

Diagnoses Disease Clinical Trial

— R-EBUS  

Official title:

Prediction Model of Benign and Malignant Peripheral Pulmonary Lesions Based on Image of Radial Endobronchial Ultrasound

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04497233
• Other study ID #: SHCHE202001
• Status: Recruiting
• Start date: July 1, 2018
• Est. completion date: March 31, 2021

Study information

• Verified date: July 2020
• Source: Shanghai Chest Hospital
• Contact: Jiayuan Sun, PhD
• Phone: 18017321598
• Email: jysun1976[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Peripheral pulmonary lesions(PPLs) have a wide spectrum of diseases, and the diagnosis will affect the treatment strategy and prognosis. Radial endobronchial ultrasound (R-EBUS) can be used for non-invasive diagnosis of PPLs, and the supplement pathological diagnosis results of EBUS-TBLB, which has important clinical application value. This project intends to select representative images from R-EBUS dynamic videos for qualitative and quantitative analysis, to establish and verify the diagnostic evaluation system of R-EBUS forPPLs. Then build 1,000 R-EBUS image databases of PPLs, train deep learning networks for automatic extraction and diagnosis of target areas, and automatically extract representative images from videos to establish a benign and malignant prediction model of PPLs. We will provide reliable theoretical basis for the diagnosis of PPLs, and optimize the diagnosis and treatment method.The network would be prospectively verified through 300 R-EBUS images from multi centers.

Description:

PPLs are lesions at tertiary bronchus and above. The lesion cannot be seen by conventional bronchoscopy and the diagnosis will affect the treatment strategy and prognosis. R-EBUS can be used for non-invasive diagnosis of PPLs, and the supplement pathological diagnosis results of EBUS-TBLB. During the procedure, target PPLs are examined by ultrasound host (EU-ME2, Olympus, Tokyo, Japan) equipped with Doppler function and ultrasound probe . The bronchoscope reaches the distal as far as possible according to the predetermined position on chest CT or positron emission tomography-computed tomography (PET-CT) . The R-EBUS probe is inserted into the working channel of the bronchoscope, and gradually approaches the target PPL to obtain R-EBUS image. According to the characteristics such as within or adjacent to image, the probe scan the lesion from the near end to the far end and record the video. The recording time is required longer than 10 seconds. After selecting a typical R-EBUS image, freeze the image and take a screenshot. The long and short diameter of the lesion will be measured. This project includes three parts: preliminary construction and evaluation of R-EBUS image system for benign and malignant PPLs, construction of R-EBUS artificial intelligence prediction model and multi-center prospective validation of the prediction model. A total of 1000 patients will be enrolled to construct diagnostic model and 300 are enrolled to verify the diagnostic effiency.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1300
• Est. completion date: March 31, 2021
• Est. primary completion date: September 30, 2020
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Patients with PPLs in Chest CT or PET / CT;

2. Chest CT or PET / CT shows PPLs with diameter greater than 8 mm;

3. Patients agree to perform EBUS-TBLB and sign the informed consent.

Exclusion Criteria:

1. Thin-layer Chest CT or PET / CT indicates lack of bronchial access to PPLs;

2. Patients refuse to participate in this clinical trial;

3. Patients with severe cardiopulmonary dysfunction or other indications that not allowed for bronchoscopy;

4. Visible lesions in the lumen during conventional bronchoscopy;

5. Patients have other related contraindications of bronchoscopy;

6. Patients have other reasons unfit for this study.

Related Conditions & MeSH terms

• Diagnoses Disease

Locations

Country	Name	City	State
China	Shanghai Chest Hospital	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai Chest Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diagnostic efficacy of R-EBUS prediction model.	Diagnostic efficacy includes sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy	18 months
Secondary	Diagnostic efficacy of traditional qualitative and quantitative methods	Diagnostic efficacy includes sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy	18 months